nach oben

Current Hypertension Reports

Erschienen in:

01.06.2018 | Sleep and Hypertension (SJ Thomas, Section Editor)

Insomnia, Short Sleep Duration, and High Blood Pressure: Recent Evidence and Future Directions for the Prevention and Management of Hypertension

verfasst von: Christina J. Bathgate, Julio Fernandez-Mendoza

Erschienen in: Current Hypertension Reports | Ausgabe 6/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

To summarize research from the past 2 years on the association between insomnia, short sleep duration, and hypertension and provide a critical analysis of the evidence and suggestions for future directions in this field.

Recent Findings

Evidence indicates that the association between insomnia and elevated blood pressure (BP) or stage 1 and 2 hypertension is stronger in those with chronic insomnia, as compared to those with isolated insomnia symptoms, and primarily found in those with the insomnia with objective short sleep duration phenotype. There is a key gap in ambulatory BP monitoring across the sleep-wake cycle as well as in randomized clinical trials testing the effectiveness of pharmacological or cognitive-behavioral insomnia therapies in lowering BP.

Summary

Insomnia is a strong candidate to join the list of risk factors for hypertension along with obstructive sleep apnea. In the meantime, chronic insomnia should become part of the routine assessment of patients with elevated BP and should be a source for referral, diagnostic evaluation, and treatment, rather than regarded as a symptom of the underlying medical disorder.

Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017; https://doi.org/10.1016/j.jacc.2017.11.006.

Ahmad M, Makati D, Akbar S. Review of and updates on hypertension in obstructive sleep apnea. Int J Hypertens. 2017;2017:1848375:1–13. https://doi.org/10.1155/2017/1848375. CrossRef

American Academy of Sleep Medicine. International classification of sleep disorders. 3rd ed. Darien: Author; 2014.

American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: Author; 2013.CrossRef

Taylor DJ, Lichstein KL, Durrence HH, Reidel BW, Bush AJ. Epidemiology of insomnia, depression, and anxiety. Sleep. 2005;28(11):1457–64.CrossRefPubMed

Monroe LJ. Psychological and physiological differences between good and poor sleepers. J Abnorm Psychol. 1967;72(3):255–64.CrossRefPubMed

Kales A, Kales JD. Evaluation and treatment of iInsomnia. New York: Oxford University Press; 1984.

Taylor DJ, Lichstein KL, Durrence HH. Insomnia as a health risk factor. Behav Sleep Med. 2003;1(4):227–47. https://doi.org/10.1207/s15402010bsm0104_5.CrossRefPubMed

• St-Onge MP, Grandner MA, Brown D, Conroy MB, Jean-Louis G, Coons M, et al. Sleep duration and quality: impact on lifestyle behaviors and cardiometabolic health: a scientific statement from the American Heart Association. Circulation. 2016;134(18):e367–e86. https://doi.org/10.1161/cir.0000000000000444. This scientific statement supports sleep quality, including insomnia, and short sleep duration as potential risk factors for cardiometabolic health, including hypertension. CrossRefPubMedPubMedCentral

10.

• Meng L, Zheng Y, Hui R. The relationship of sleep duration and insomnia to risk of hypertension incidence: a meta-analysis of prospective cohort studies. Hypertens Res. 2013;36(11):985–95. This is the only available meta-analysis to date that has examined the association of insomnia with hypertension CrossRefPubMedPubMedCentral

11.

• Hall M, Fernandez-Mendoza J, Kline CN, Vgontzas A. Insomnia and health. In: Kryger MH, Roth T, Dement WC, editors. Principles and practice of sleep medicine. 6th ed. New York: Elsevier Academic Press; 2016. p. 794–803. This is a comprehensive review in a handbook of references for clinicians and researchers on the association of insomnia with adverse cardiovascular and metabolic health outcomes.

12.

• Fernandez-Mendoza J. The insomnia with short sleep duration phenotype: an update on it's importance for health and prevention. Curr Opin Psychiatry. 2017;30(1):56–63. https://doi.org/10.1097/yco.0000000000000292. This paper brielfy reviews the 2013-2017 evidence, beyond cardiometabolic outcomes, on the insomnia with objective short sleep duration phenotype CrossRefPubMed

13.

Sofi F, Cesari F, Casini A, Macchi C, Abbate R, Gensini GF. Insomnia and risk of cardiovascular disease: a meta-analysis. Eur J Prev Cardiol. 2014;21(1):57–64. https://doi.org/10.1177/2047487312460020.CrossRefPubMed

14.

Thomas SJ, Calhoun D. Sleep, insomnia, and hypertension: current findings and future directions. J Am Soc Hypertens: JASH. 2017;11(2):122–9. https://doi.org/10.1016/j.jash.2016.11.008.CrossRefPubMed

15.

Guo X, Zheng L, Wang J, Zhang X, Zhang X, Li J, et al. Epidemiological evidence for the link between sleep duration and high blood pressure: a systematic review and meta-analysis. Sleep Med. 2013;14(4):324–32. https://doi.org/10.1016/j.sleep.2012.12.001.CrossRefPubMed

16.

Vgontzas AN, Fernandez-Mendoza J. Insomnia with short sleep duration: nosological, diagnostic, and treatment implications. Sleep Med Clin. 2013;8(3):309–22. https://doi.org/10.1016/j.jsmc.2013.04.009.CrossRefPubMedPubMedCentral

17.

• Vgontzas AN, Fernandez-Mendoza J, Liao D, Bixler EO. Insomnia with objective short sleep duration: the most biologically severe phenotype of the disorder. Sleep Med Rev. 2013;17(4):241–54. This review first established the underlying pathophysiologic and phenotyping model of insomnia with objective short sleep duration CrossRefPubMedPubMedCentral

18.

Shivashankar R, Kondal D, Ali MK, Gupta R, Pradeepa R, Mohan V, Kadir MM, Narayan KMV, Tandon N, Prabhakaran D, Peasey A Associations of sleep duration and disturbances with hypertension in metropolitan cities of Delhi, Chennai, and Karachi in South Asia: cross-sectional analysis of the CARRS study. Sleep 2017;40(9). https://doi.org/10.1093/sleep/zsx119.

19.

Wang YM, Song M, Wang R, Shi L, He J, Fan TT, et al. Insomnia and multimorbidity in the community elderly in China. J Clin Sleep Med. 2017;13(4):591–7. https://doi.org/10.5664/jcsm.6550.CrossRefPubMedPubMedCentral

20.

Clark AJ, Salo P, Lange T, Jennum P, Virtanen M, Pentti J, et al. Onset of impaired sleep and cardiovascular disease risk factors: a longitudinal study. Sleep. 2016;39(9):1709–18. https://doi.org/10.5665/sleep.6098.CrossRefPubMedPubMedCentral

21.

Leigh L, Hudson IL, Byles JE. Sleep difficulty and disease in a cohort of very old women. J Aging Health. 2016;28(6):1090–104. https://doi.org/10.1177/0898264315624907.CrossRefPubMed

22.

Hauan M, Strand LB, Laugsand LE. Associations of insomnia symptoms with blood pressure and resting heart rate: the HUNT study in Norway. Behav Sleep Med. 2016;1–21. https://doi.org/10.1080/15402002.2016.1228651.

23.

Wang Y, Jiang T, Wang X, Zhao J, Kang J, Chen M, et al. Association between insomnia and metabolic syndrome in a Chinese Han population: a cross-sectional study. Sci Rep. 2017;7(1):10893. https://doi.org/10.1038/s41598-017-11431-6. CrossRefPubMedPubMedCentral

24.

Ramos AR, Weng J, Wallace DM, Petrov MR, Wohlgemuth WK, Sotres-Alvarez D, et al. Sleep patterns and hypertension using actigraphy in the Hispanic community health study/study of Latinos. Chest. 2018;153(1):87–93. https://doi.org/10.1016/j.chest.2017.09.028.CrossRefPubMed

25.

Lin CL, Liu TC, Lin FH, Chung CH, Chien WC. Association between sleep disorders and hypertension in Taiwan: a nationwide population-based retrospective cohort study. J Hum Hypertens. 2017;31(3):220–4. https://doi.org/10.1038/jhh.2016.55.CrossRefPubMed

26.

Deng HB, Tam T, Zee BC, Chung RY, Su X, Jin L et al. Short sleep duration increases metabolic impact in healthy adults: a population-based cohort study. Sleep 2017;40(10). https://doi.org/10.1093/sleep/zsx130.

27.

Chen IY, Jarrin DC, Ivers H, Morin CM. Investigating psychological and physiological responses to the Trier Social Stress Test in young adults with insomnia. Sleep Med. 2017;40:11–22. https://doi.org/10.1016/j.sleep.2017.09.011.CrossRefPubMed

28.

Kalmbach DA, Pillai V, Arnedt JT, Drake CL. DSM-5 insomnia and short sleep: comorbidity landscape and racial disparities. Sleep. 2016;39(12):2101–11. https://doi.org/10.5665/sleep.6306.CrossRefPubMedPubMedCentral

29.

• Bathgate CJ, Edinger JD, Wyatt JK, Krystal AD. Objective, but not subjective short sleep duration associated with increased risk for hypertension in individuals with insomnia. Sleep. 2016;39(5):1037–45. https://doi.org/10.5665/sleep.5748. This study replicated the finding that insomnia with objective short sleep duration is associated with increased hypertension risk in an independent sample of individuals with chronic insomnia disorder CrossRefPubMedPubMedCentral

30.

Wang Q, Xi B, Liu M, Zhang Y, Fu M. Short sleep duration is associated with hypertension risk among adults: a systematic review and meta-analysis. Hypertens Res. 2012;35(10):1012–8. https://doi.org/10.1038/hr.2012.91.CrossRefPubMed

31.

Vgontzas AN, Liao D, Bixler EO, Chrousos GP, Vela-Bueno A. Insomnia with objective short sleep duration is associated with a high risk for hypertension. Sleep. 2009;32(4):491–7.CrossRefPubMedPubMedCentral

32.

Fernandez-Mendoza J, Vgontzas AN, Liao D, Shaffer ML, Vela-Bueno A, Basta M, et al. Insomnia with objective short sleep duration and incident hypertension: the Penn State Cohort. Hypertension. 2012;60(4):929–35.CrossRefPubMedPubMedCentral

33.

• Johann AF, Hertenstein E, Kyle SD, Baglioni C, Feige B, Nissen C, et al. Insomnia with objective short sleep duration is associated with longer duration of insomnia in the Freiburg Insomnia Cohort compared to insomnia with normal sleep duration, but not with hypertension. PLoS One. 2017;12(7):e0180339. https://doi.org/10.1371/journal.pone.0180339. This study could not replicate the finding that insomnia with objective short sleep duration is associated with increased hypertension risk in an independent sample of clinically-referred patients with chronic insomnia disorder CrossRefPubMedPubMedCentral

34.

Hnin K, Mukherjee S, Antic NA, Catcheside P, Chai-Coetzer CL, McEvoy RD, et al. The impact of ethnicity on the prevalence and severity of obstructive sleep apnea. Sleep Med Rev. 2018; https://doi.org/10.1016/j.smrv.2018.01.003.

35.

Neuhauser H, Diederichs C, Boeing HB, Felix S, Jünger C, Lorbeer R, et al. Hypertension in Germany: data from seven population-based epidemiological studies (1994–2012). Dtsch Arztebl Int. 2016;113(48):809–15. https://doi.org/10.3238/arztebl.2016.0809.PubMedPubMedCentralCrossRef

36.

Benjamin EJ, Virani SS, Callaway CW, Chang AR, Cheng S, Chiuve SE, et al. Heart disease and stroke statistics—2018 update: a report from the American Heart Association. In: Circulation, vol. 137; 2018. p. e67–e492.

37.

Edinger JD, Wyatt JK, Stepanski EJ, Olsen MK, Stechuchak KM, Carney CE, et al. Testing the reliability and validity of DSM-IV-TR and ICSD-2 insomnia diagnoses. Results of a multitrait-multimethod analysis. Arch Gen Psychiatry. 2011;68(10):992–1002.CrossRefPubMed

38.

Conen D, Bamberg F. Noninvasive 24-h ambulatory blood pressure and cardiovascular disease: a systematic review and meta-analysis. J Hypertens. 2008;26(7):1290–9. https://doi.org/10.1097/HJH.0b013e3282f97854.CrossRefPubMed

39.

Fan HQ, Li Y, Thijs L, Hansen TW, Boggia J, Kikuya M, et al. Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations. J Hypertens. 2010;28(10):2036–45. https://doi.org/10.1097/HJH.0b013e32833b49fe.CrossRefPubMed

40.

Baglioni C, Regen W, Teghen A, Spiegelhalder K, Feige B, Nissen C, et al. Sleep changes in the disorder of insomnia: a meta-analysis of polysomnographic studies. Sleep Med Rev. 2014;18(3):195–213. https://doi.org/10.1016/j.smrv.2013.04.001.CrossRefPubMed

41.

• Nano MM, Fonseca P, Vullings R, Aarts RM. Measures of cardiovascular autonomic activity in insomnia disorder: a systematic review. PLoS One. 2017;12(10):e0186716. https://doi.org/10.1371/journal.pone.0186716. This systematic review summarizes the state-of-the-art in the association of insomnia with diverse indices of cardiac autonomic modulation CrossRefPubMedPubMedCentral

42.

Li Y, Vgontzas AN, Fernandez-Mendoza J, Bixler EO, Sun Y, Zhou J, et al. Insomnia with physiological hyperarousal is associated with hypertension. Hypertension. 2015;65(3):644–50.CrossRefPubMed

43.

Edinger JD, Means MK, Krystal AD. Does physiological hyperarousal enhance error rates among insomnia sufferers? Sleep. 2013;36(8):1179–86. https://doi.org/10.5665/sleep.2882.CrossRefPubMedPubMedCentral

44.

Fernandez-Mendoza J, Shea S, Vgontzas AN, Calhoun SL, Liao D, Bixler EO. Insomnia and incident depression: role of objective sleep duration and natural history. J Sleep Res. 2015;24:390–8. https://doi.org/10.1111/jsr.12285.CrossRefPubMed

45.

Fernandez-Mendoza J, Vgontzas AN, Bixler EO, Singareddy R, Shaffer ML, Calhoun SL, et al. Clinical and polysomnographic predictors of the natural history of poor sleep in the general population. Sleep. 2012;35(5):689–97. https://doi.org/10.5665/sleep.1832.CrossRefPubMedPubMedCentral

46.

Singareddy R, Vgontzas AN, Fernandez-Mendoza J, Liao D, Calhoun S, Shaffer ML, et al. Risk factors for incident chronic insomnia: a general population prospective study. Sleep Med. 2012;13(4):346–53. https://doi.org/10.1016/j.sleep.2011.10.033.CrossRefPubMedPubMedCentral

47.

Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians management of chronic insomnia disorder in adults. Ann Intern Med. 2016;165(2):125–33. https://doi.org/10.7326/M15-2175. CrossRefPubMed

48.

Li Y, Yang Y, Li Q, Yang X, Wang Y, Ku WL, et al. The impact of the improvement of insomnia on blood pressure in hypertensive patients. J Sleep Res. 2017;26(1):105–14. https://doi.org/10.1111/jsr.12411.CrossRefPubMed

49.

McGrath ER, Espie CA, Power A, Murphy AW, Newell J, Kelly C, et al. Sleep to lower elevated blood pressure: a randomized controlled trial (SLEPT). Am J Hypertens. 2017;30(3):319–27. https://doi.org/10.1093/ajh/hpw132.CrossRefPubMed

50.

Bathgate CJ, Edinger JD, Krystal AD. Insomnia patients with objective short sleep duration have a blunted response to cognitive behavioral therapy for insomnia. Sleep 2017;40(1). https://doi.org/10.1093/sleep/zsw012.

Titel: Insomnia, Short Sleep Duration, and High Blood Pressure: Recent Evidence and Future Directions for the Prevention and Management of Hypertension
verfasst von: Christina J. Bathgate
Julio Fernandez-Mendoza
Publikationsdatum: 01.06.2018
Verlag: Springer US
Erschienen in: Current Hypertension Reports / Ausgabe 6/2018
Print ISSN: 1522-6417
Elektronische ISSN: 1534-3111
DOI: https://doi.org/10.1007/s11906-018-0850-6

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Insomnia, Short Sleep Duration, and High Blood Pressure: Recent Evidence and Future Directions for the Prevention and Management of Hypertension

Abstract

Purpose of Review

Recent Findings

Summary

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2018

Carotid Body Ablation: a New Target to Address Central Autonomic Dysfunction

Genetics of Resistant Hypertension: the Missing Heritability and Opportunities

Dietary Modifications and Lipid Accumulation Product Are Associated with Systolic and Diastolic Blood Pressures in the Women’s Health Trial: Feasibility Study in Minority Populations

Update on Endothelin Receptor Antagonists in Hypertension

ConfidenHT™ System for Diagnostic Mapping of Renal Nerves

Recent Findings in the Genetics of Blood Pressure: How to Apply in Practice or Is a Moonshot Required?

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin